Key result
Access to genetic testing was associated with significantly greater patient empowerment compared to no testing (mean GCOS-24 score 121.14 vs 105.68).
Why the study?
Access to healthcare providers differs across multidisciplinary clinics in Canada, and little is known about the relationship between access to specialty care and an inherited cardiac condition patient's ability to cope and manage their condition.
Does access to specialty care and genetic testing improve perceived self-efficacy and empowerment in patients with inherited cardiac conditions?
Cross-Sectional (n=235)
Yes
Does access to specialty care and genetic testing improve perceived self-efficacy and empowerment in patients with inherited cardiac conditions?
Absolute Event Rate: 121.14% vs 105.68%
p-value: p=0.004
In patients with inherited cardiac conditions, access to genetic testing and definitive results improves patient empowerment and self-efficacy, highlighting the importance of specialized multidisciplinary care.
May support genetic testing access for empowerment in inherited cardiac conditions; hypothesis-generating and requires prospective trials before practice change.
Background The role of multidisciplinary clinics for psychosocial care is increasingly recognized for those living with inherited cardiac conditions (ICC). In Canada, access to healthcare providers differ between clinics. Little is known about the relationship between access to specialty care and a patient's ability to cope with, and manage their condition. Methods We leveraged the Hearts in Rhythm Organization (HiRO) to conduct a cross-sectional, community-based survey of individuals with ICC and their family members. We aimed to describe access to services, and explore the relationships between participants’ characteristics, cardiac history and self-reported health status and self-efficacy (GSE: General Self-Efficacy Scale) and empowerment (GCOS-24: Genetic Counseling Outcome Scale). Results We collected 235 responses from Canadian participants in 10 provinces and territories. Overall, 63% of participants reported involvement of a genetic counsellor in their care. Access to genetic testing was associated with greater empowerment [mean GCOS-24: 121.14 (SD = 20.53) vs. 105.68 (SD = 21.69); p = 0.004]. Uncertain genetic test results were associated with lower perceived self-efficacy (mean GSE: uncertain = 28.85 vs. positive = 33.16, negative = 34.13; p = 0.01). Low global mental health scores correlated with both lower perceived self-efficacy and empowerment scores, with only 11% of affected participants reporting involvement of psychology services in their care. Conclusion Differences in resource accessibility, clinical history and self-reported health status impact the perceived self-efficacy and empowerment of patients with ICC. Future research evaluating interventions to improve patient outcomes is recommended.
No takes yet. Share an insight, caveat, or question.
Davies et al. (2023) conducted a cross-sectional in Inherited cardiac conditions (ICC) or unexplained cardiac arrest (n=235). Access to genetic testing vs. No access to genetic testing was evaluated on Patient empowerment (GCOS-24 score) (p=0.004). Access to genetic testing was associated with significantly greater patient empowerment compared to no testing (mean GCOS-24 score 121.14 vs 105.68).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: